Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose hydrocortisone for post-cardiotomy low cardiac output syndrome in adults
ChiCTR2600124036Phase 4Not yet recruiting
- Sponsor
- Subei People's Hospital
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hydrocortisone in low cardiac output syndrome (LCOS) (2 arms), sponsored by Subei People's Hospital. Primary endpoint: Vasopressor-free days. Planned start May 2026; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
low cardiac output syndrome (LCOS)
Beyond the preview
Go deeper on ChiCTR2600124036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124036.